Paris, France

Salman Al Mahmood

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Gene Signal International Sa. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Salman Al Mahmood. Retrieved from https://idiyas.com/inventor/salman-al-mahmood-a28827lr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 40.0


 

Average Co-Inventor Count = 1.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Salman Al Mahmood

Introduction

Salman Al Mahmood is an accomplished inventor based in Paris, France, known for his groundbreaking work in the field of biotechnology. With an impressive portfolio of five patents, Al Mahmood has made significant contributions to medical science, particularly in the development of anti-tumor therapies.

Latest Patents

Among his latest patents are innovative formulations aimed at treating cancers and tumors. One notable patent details a method for cancer treatment that involves administering a polypeptide with the specific sequence SEQ ID NO:4. This treatment is characterized by its ability to comprise polypeptides with aligned sequences that maintain a high percentage of identical residues. Another important patent features an active polypeptide with the same amino acid sequence which demonstrates anti-tumor activity, along with associated compositions and methods for its effective use.

Career Highlights

Salman Al Mahmood's career is marked by his association with Gene Signal International SA, a company dedicated to advancing medical therapies. His innovative spirit and commitment to scientific research have propelled him to the forefront of his field, making notable strides in cancer treatment.

Collaborations

Working alongside talented individuals like Sylvie Colin, Al Mahmood has fostered a collaborative environment that encourages the exchange of ideas and expertise. Their combined efforts have yielded promising advancements in medical science, particularly in the area of tumor treatment.

Conclusion

Salman Al Mahmood's dedication to innovation and improving patient outcomes through his patented inventions exemplifies the impact of biotechnology on modern medicine. With a strong foundation in research and collaboration, Al Mahmood continues to pave the way for future breakthroughs in cancer treatment. His work not only signifies a personal achievement but also represents a beacon of hope for those affected by cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…